Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mark Richards

Showing results (1-10 of 456) with videos related to

Pageof 46
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
C-type natriuretic peptide and cardiac fibrosisA Mark Richards
Nature Clinical Practice. Cardiovascular Medicine|October 3, 2007
Does NT-proBNP testing reduce costs and improve accuracy in the diagnosis of heart failure?A Mark Richards
Journal of the American College of Cardiology|November 3, 2018
ST2 and Prognosis in Chronic Heart FailureA Mark Richards
Revista Espanola De Cardiologia|October 2, 2012
[Not Available]A Mark Richards
European Journal of Heart Failure|August 9, 2022
Optimizing the diagnostic utility of N-terminal pro-B-type natriuretic peptide for acute heart failure in obesity and beyondA Mark Richards
The New Zealand Medical Journal|February 12, 2026
Inadequate resourcing for clinical science in New ZealandA Mark Richards
European Journal of Heart Failure|July 4, 2013
Brain natriuretic peptide-guided management of chronic heart failure: first do no harmA Mark Richards
European Journal of Heart Failure|September 18, 2020
Beating the bushes for biomarkersA Mark Richards
European Heart Journal|June 14, 2024
BNP as a biomarker in adult congenital heart disease: help or hype?A Mark Richards
European Journal of Heart Failure|February 16, 2021
Cardiac myosin-binding protein C as a candidate biomarker in heart failure: rational but not revolutionaryA Mark Richards
Pageof 46

Showing results (1-10 of 456) with videos related to

Sort By:
Pageof 46
Hypertension (Dallas, Tex. : 1979)|December 30, 2010
C-type natriuretic peptide and cardiac fibrosisA Mark Richards
Nature Clinical Practice. Cardiovascular Medicine|October 3, 2007
Does NT-proBNP testing reduce costs and improve accuracy in the diagnosis of heart failure?A Mark Richards
Journal of the American College of Cardiology|November 3, 2018
ST2 and Prognosis in Chronic Heart FailureA Mark Richards
Revista Espanola De Cardiologia|October 2, 2012
[Not Available]A Mark Richards
European Journal of Heart Failure|August 9, 2022
Optimizing the diagnostic utility of N-terminal pro-B-type natriuretic peptide for acute heart failure in obesity and beyondA Mark Richards
The New Zealand Medical Journal|February 12, 2026
Inadequate resourcing for clinical science in New ZealandA Mark Richards
European Journal of Heart Failure|July 4, 2013
Brain natriuretic peptide-guided management of chronic heart failure: first do no harmA Mark Richards
European Journal of Heart Failure|September 18, 2020
Beating the bushes for biomarkersA Mark Richards
European Heart Journal|June 14, 2024
BNP as a biomarker in adult congenital heart disease: help or hype?A Mark Richards
European Journal of Heart Failure|February 16, 2021
Cardiac myosin-binding protein C as a candidate biomarker in heart failure: rational but not revolutionaryA Mark Richards
Pageof 46